AAPL   318.40 (+0.05%)
MSFT   180.94 (-0.25%)
FB   224.36 (-0.49%)
GOOGL   1,422.61 (+0.31%)
AMZN   2,411.06 (+0.41%)
NVDA   343.86 (+1.35%)
CGC   17.23 (-20.67%)
BABA   198.78 (-0.36%)
GE   6.54 (-3.54%)
TSLA   810.45 (+0.58%)
AMD   52.17 (+1.07%)
T   30.74 (-1.03%)
ACB   14.12 (-7.95%)
GILD   75.22 (+0.00%)
DIS   114.86 (-1.62%)
BAC   24.52 (-1.37%)
BA   145.10 (-2.88%)
AAPL   318.40 (+0.05%)
MSFT   180.94 (-0.25%)
FB   224.36 (-0.49%)
GOOGL   1,422.61 (+0.31%)
AMZN   2,411.06 (+0.41%)
NVDA   343.86 (+1.35%)
CGC   17.23 (-20.67%)
BABA   198.78 (-0.36%)
GE   6.54 (-3.54%)
TSLA   810.45 (+0.58%)
AMD   52.17 (+1.07%)
T   30.74 (-1.03%)
ACB   14.12 (-7.95%)
GILD   75.22 (+0.00%)
DIS   114.86 (-1.62%)
BAC   24.52 (-1.37%)
BA   145.10 (-2.88%)
AAPL   318.40 (+0.05%)
MSFT   180.94 (-0.25%)
FB   224.36 (-0.49%)
GOOGL   1,422.61 (+0.31%)
AMZN   2,411.06 (+0.41%)
NVDA   343.86 (+1.35%)
CGC   17.23 (-20.67%)
BABA   198.78 (-0.36%)
GE   6.54 (-3.54%)
TSLA   810.45 (+0.58%)
AMD   52.17 (+1.07%)
T   30.74 (-1.03%)
ACB   14.12 (-7.95%)
GILD   75.22 (+0.00%)
DIS   114.86 (-1.62%)
BAC   24.52 (-1.37%)
BA   145.10 (-2.88%)
AAPL   318.40 (+0.05%)
MSFT   180.94 (-0.25%)
FB   224.36 (-0.49%)
GOOGL   1,422.61 (+0.31%)
AMZN   2,411.06 (+0.41%)
NVDA   343.86 (+1.35%)
CGC   17.23 (-20.67%)
BABA   198.78 (-0.36%)
GE   6.54 (-3.54%)
TSLA   810.45 (+0.58%)
AMD   52.17 (+1.07%)
T   30.74 (-1.03%)
ACB   14.12 (-7.95%)
GILD   75.22 (+0.00%)
DIS   114.86 (-1.62%)
BAC   24.52 (-1.37%)
BA   145.10 (-2.88%)
Log in

NASDAQ:MACKMerrimack Pharmaceuticals Earnings Date, Estimates & History

$3.28
-0.05 (-1.50 %)
(As of 05/29/2020 11:22 AM ET)
Add
Compare
Today's Range
$3.28
Now: $3.28
$3.40
50-Day Range
$3.34
MA: $3.57
$3.88
52-Week Range
$1.49
Now: $3.28
$7.09
Volume5,046 shs
Average Volume23,372 shs
Market Capitalization$43.89 million
P/E RatioN/A
Dividend YieldN/A
Beta2.49

Earnings

Merrimack Pharmaceuticals (NASDAQ:MACK) Earnings Information

Merrimack Pharmaceuticals last released its earnings data on May 7th, 2020. The biopharmaceutical company reported $0.02 earnings per share (EPS) for the quarter. Merrimack Pharmaceuticals has generated $0.00 earnings per share over the last year. Merrimack Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, July 15th, 2020 based off prior year's report dates.

Merrimack Pharmaceuticals Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Merrimack Pharmaceuticals (NASDAQ MACK) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
7/15/2020
(Estimated)
       
5/7/2020Q1 2020$0.02$0.02N/A
11/12/2019Q3 2019($0.05)($0.05)N/A
7/17/2019Q2 2019($0.71)($0.71)N/A
5/10/20193/31/2019($0.92)($0.78)($0.78)N/A
3/6/2019Q4 2018($1.01)($0.97)($0.97)N/A
11/7/20189/30/2018($0.27)($0.92)($2.14)$23.00 millionN/A
8/7/2018Q2 2018($1.28)($1.33)($1.33)N/A
5/8/2018Q1 2018($1.28)($1.33)($1.33)N/A
3/12/2018Q4 2017($1.27)($0.89)($0.89)N/A
11/8/2017Q3 2017($1.88)($0.40)($1.04)N/A
8/9/2017Q2 2017($1.37)($2.18)($4.30)$18.00 millionListen
5/10/2017Q1 2017($0.70)($2.20)($0.21)$32.16 millionN/A
3/1/2017Q416($2.10)($2.50)($0.25)$50.44 million$61.20 millionListen
11/9/2016Q316($2.70)($2.30)($0.23)$41.00 million$28.07 millionListen
8/4/2016Q216($3.30)($4.00)($0.40)$33.35 million$33.70 millionN/A
5/2/2016Q116($3.80)($3.30)($0.33)$24.16 million$21.30 millionN/A
2/25/2016Q415($4.10)($4.10)($0.41)$31.73 million$21.42 millionListen
11/9/2015Q315($4.00)($3.80)($0.38)$14.04 million$16.44 millionN/A
8/10/2015Q215($3.10)($2.10)($0.21)$17.57 million$36.60 millionListen
5/7/2015Q1 2015($3.00)($3.20)($0.32)$14.50 million$14.84 millionN/A
2/26/2015Q4($2.30)($0.90)($0.09)$25.13 million$33.91 millionN/A
11/10/2014Q3 2014($1.20)($2.70)($0.27)$61.50 million$28.00 millionN/A
8/11/2014Q2 2014($3.20)($1.70)($0.17)$10.83 million$27.82 millionN/A
5/1/2014Q114($3.10)($2.70)($0.27)$11.93 million$13.03 millionN/A
2/27/2014Q4 2013($3.40)($3.30)($3.30)$11.61 million$7.82 millionN/A
11/7/2013Q3 2013($3.40)($3.90)($3.90)$15.86 million$6.86 millionN/A
8/8/2013Q2 2013($2.90)($3.10)($3.10)$13.68 million$18.45 millionListen
5/13/2013Q1 2013($2.80)($2.90)($2.90)$11.68 million$14.66 millionN/A
3/14/2013Q4 2012($2.60)($17.60)$11.77 million$12.58 millionN/A
11/14/2012Q312($18.10)$8.60 million$11.30 millionN/A
8/10/2012Q2 2012($2.70)($2.21)($2.21)N/A
5/15/2012Q1 2012($2.30)($21.40)($21.40)N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 5/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.